ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

ImStem, UConn Obtain US Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases – Multiple Sclerosis News Today

Multiple Sclerosis News TodayImStem, UConn Obtain US Patent for Mesenchymal Stem Cell Technology to Treat MS, Other DiseasesMultiple Sclerosis News TodayThe U.S. Patent and Trademark Office has issued a patent for human embryonic stem cells derived mes… Continue reading

2017-09-20 Michael Zand NEWS

Spark Therapeutics Enters into Licensing Agreement with Genethon – GlobeNewswire (press release)

Spark Therapeutics Enters into Licensing Agreement with GenethonGlobeNewswire (press release)PHILADELPHIA and EVRY, France, Sept. 20, 2017 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challe… Continue reading

2017-09-20 Michael Zand NEWS

Butterflies lose their luster if their ‘paintbrush genes’ aren’t on – Mother Nature Network

Continue reading

2017-09-20 Michael Zand NEWS

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in … – PR Newswire (press release)

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in …PR Newswire (press release)SAN FRANCISCO, Sept. 20, 2017 /PRNewswire-USNewswire/ — The Parker Institute for Cancer Immunotherapy and … Continue reading

2017-09-20 Michael Zand NEWS

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in … – PR Newswire (press release)

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in …PR Newswire (press release)SAN FRANCISCO, Sept. 20, 2017 /PRNewswire-USNewswire/ — The Parker Institute for Cancer Immunotherapy and … Continue reading

2017-09-20 Michael Zand NEWS

Sean Parker institute to lead immunotherapy trial for pancreatic cancer – SFGate


Mother Nature Network

Butterflies lose their luster if their ‘paintbrush genes’ aren’t on
Mother Nature Network
The two genes, WntA and optix, had previously been shown to play a part how butterflies’ wings’ patterns and colors, but it wasn’t until scientists switched on and off the genes using the CRISPR-Cas9 technique that they discovered just how big a part …

and more »

Continue reading

2017-09-20 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed Higher Than Its 50 Day Moving Average – Finance Daily

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed Higher Than Its 50 Day Moving AverageFinance DailyCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prev… Continue reading

2017-09-20 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed Higher Than Its 50 Day Moving Average – Finance Daily

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed Higher Than Its 50 Day Moving AverageFinance DailyCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prev… Continue reading

2017-09-20 Michael Zand NEWS
  • 1
  • …
  • 1,178
  • 1,179
  • 1,180
  • 1,181
  • 1,182
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

SFGate

Sean Parker institute to lead immunotherapy trial for pancreatic cancer
SFGate
The Parker Institute for Cancer Immunotherapy, the San Francisco nonprofit created in 2016 with $250 million from the billionaire former Facebook executive who helped build Napster, will sponsor its first clinical trial — an immunotherapy treatment …

and more »